Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeReferences to previous work
Posted by ZvBentwich on 20 Feb 2019 at 08:28 GMT
Based on our studies in Ethiopian Immigrants to Israel starting from 1992, we have put forward the hypothesis that helminths' infections (including schistosomiasis) make the host more susceptible to HIV and less able to cope with the infection. These, we argued , are due to the immune activation, the skewed cytokine profile and the increased expression of HIV co receptors-CCR5 and CXCR4. Moreover , we were able to demonstrate that PBMC obtained from these individuals were more susceptible to infection with HIV in vitro. Since these studies and publications preceded all the cited studies in the article, and have likely contributed to the basis for their initiation , I believe they should have been cited in the article.
Bentwich Z, Kalinkovich A & Weisman Z. Immune activation is a dominant factor in the pathogenesis of African AIDS. Immunol Today 1995; 16: 187–191.
Bentwich Z, Kalinkovich A, Weisman Z, Borkow G, Beyers N & Beyers AD. Can eradication of helminthic infections change the face of AIDS and tuberculosis? Immunol Today 1999; 20:485–487.
Kalinkovich A, Borkow G, Weisman Z, Tsimanis A, Stein M& Bentwich Z. Increased CCR5 and CXCR4 expression in Ethiopians living in Israel: environmental and constitutive factors. Clin Immunol 2001; 100: 107–117.
Shapira-Nahor O, Kalinkovich A, Weisman Z et al. Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS 1998; 12: 1731–1733.